Orange Book product · Brand (NDA)
TAMIFLU
OSELTAMIVIR PHOSPHATE
At a glance
Dec 14, 2000
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 14, 2000
25 yr 11 mo ago
Today
Pharmaceutical detail
Active ingredient
OSELTAMIVIR PHOSPHATE
Strength
EQ 12MG BASE/ML
Dosage form
FOR SUSPENSION
Route
ORAL
TE code
Not listed
Application
NDA 021246
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a brand (NDA) product. Other products sharing this active ingredient are listed below.
- 2007TAMIFLUBrand (NDA)
NDA 021087 · ROCHE
- 2026OSELTAMIVIR PHOSPHATEGeneric (ANDA)
ANDA 213437 · UPSHER SMITH LABS
- 2025OSELTAMIVIR PHOSPHATEGeneric (ANDA)
ANDA 218009 · ZHEJIANG POLY PHARM
- 2025OSELTAMIVIR PHOSPHATEGeneric (ANDA)
ANDA 217274 · SHANDONG
- 2025OSELTAMIVIR PHOSPHATEGeneric (ANDA)
ANDA 213695 · JUBILANT GENERICS
- 2024OSELTAMIVIR PHOSPHATEGeneric (ANDA)
ANDA 217451 · CEDIPROF INC
- 2024OSELTAMIVIR PHOSPHATEGeneric (ANDA)
ANDA 217133 · BEIJING JIALIN
- 2024OSELTAMIVIR PHOSPHATEGeneric (ANDA)
ANDA 217303 · PHARMOBEDIENT
- 2024OSELTAMIVIR PHOSPHATEGeneric (ANDA)
ANDA 218131 · AUROBINDO PHARMA LTD
- 2024OSELTAMIVIR PHOSPHATEGeneric (ANDA)
ANDA 218565 · LAURUS
- 2023OSELTAMIVIR PHOSPHATEGeneric (ANDA)
ANDA 217467 · INVAGEN PHARMS
- 2023OSELTAMIVIR PHOSPHATEGeneric (ANDA)
ANDA 215538 · EPIC PHARMA LLC
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

